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T
ransferring a terminally differ-
entiated cell nucleus into an egg 
cell that has had its own nucleus 
removed wipes away the epigenetic marks 
of differentiation and allows the nucleus 
once again to code for any cell type. 
Whether this trick was even possible was 
a fundamental question of developmental 
biology until Konrad Hochedlinger, as a 
Ph.D. student, fi  nally 
delivered unequivocal 
proof (1).
Nuclear transfer is 
one of the most so-
phisticated, fi  ckle, and 
challenging techniques 
in cell biology. At-
tempting it as a fresh-
faced Ph.D. student 
is brave. Even his 
supervisor was wor-
ried. “He thought it was very risky and 
may not work at all, but I tried it any-
way,” Hochedlinger says with disarming 
nonchalance.
At just 31 years old, Hochedlinger has 
already worked on therapeutic cloning in 
a mouse model (2), reprogramming cancer 
nuclei (3), and the molecular mechanisms 
controlling stem cell pluripotency (4). He 
has now been running his own lab at 
Harvard University for a year and a half. 
In a recent interview, he spoke with great 
enthusiasm about the new challenges of 
being a lab leader, about his remarkable 
career so far, and about the new direction 
in which he thinks reprogramming re-
search is headed.
EARLY DEVELOPMENT
How did you get started in science?
My older sister got me into science. She 
studied biology at university. When I 
was deciding what to study, I was torn 
between medicine and biology. My sis-
ter told me that biology was really cool 
and that I should try it out. So it’s my 
sister’s fault. [laughs]
Since then, it has always been biology. 
As soon as I took my fi  rst genetics class at 
university (University of Vienna, Austria), 
I got really interested. Genetics provides 
an ideal tool for dissecting what humans 
or animals are about. As soon as I had my 
fi  rst lecture in genetics, I knew I defi  nitely 
wanted to continue on that route.
What was the next step on that route?
I went to the Institute of Molecular 
Pathology (IMP, Vienna) to do my 
Master’s thesis. I joined Erwin Wagner’s 
lab. He studies bone development in 
mice. He makes knockout and trans  genic 
mice to study the function of genes in 
bone development and cancer. Erwin’s 
lab was where I got exposed to real 
science for the fi  rst time.
You went from studying bone development 
to asking more fundamental questions 
about development and its reversibility. 
How did you get interested in that?
I got interested in cloning during my 
undergraduate course, when I learned 
about John Gurdon’s classic frog cloning 
experiments. It fascinated me. Then in ’97 
the paper by Ian Wilmut came out on the 
cloning of Dolly the sheep. Before that, 
nuclear reprogramming hadn’t been 
shown in mammals. It was thought that 
mammalian cells 
might be refrac-
tory to cloning.
The reason I 
then was drawn 
into epigenetics 
and stem cell bi-
ology was a lec-
ture at the IMP by 
Rudolf Jaenisch. 
I was really fascinated by the data he pre-
sented on the role of epigenetics in cloning 
and reprogramming.
SPECIALIZATION
That inspired you to apply to his 
laboratory?
Yes, I decided to come to Cambridge 
(Massachusetts) to visit my sister, and I 
stopped by MIT and talked to Rudolf. I 
started in his lab in March of 2000.
What was your project there?
For my Ph.D. thesis, I worked on nuclear 
transfer. I asked whether a terminally 
differentiated cell is still amenable to 
reprogramming and able to give rise to a 
cloned animal. This question had not been 
resolved unequivocally by the cloning of 
Dolly or other mammals.
What were the limitations of 
experiments such as Dolly?
They used adult cells, but it was possible 
that the cells that gave rise to successfully 
cloned animals were derived from rare 
adult stem cells. This also might have 
explained why cloning is ineffi  cient: only 
1–3% of cloned embryos eventually de-
velop into an adult clone.
I took advantage of lymphocytes. 
These cells carry specific genetic marks 
that indicate their maturity—the genetic 
rearrangements responsible for anti-
body production. I was successful in 
cloning mice from lymphocytes and 
could show that the genetic marks were 
present in all the cells of the cloned 
mouse.
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revolutionized 
the entire 
stem cell and 
reprogramming 
field.”
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It’s quite an ambitious project for a new 
Ph.D. student!
It was a very risky project. Rudolf has 
since told me that he thought I wouldn’t 
pull it off. He thought it might not work at 
all, that you might not be able to clone 
from fully differentiated cells.
After your Ph.D. you stayed in the 
same lab for your postdoc?
I stayed on in Rudolf’s lab for another 
three years to do a postdoc, because I 
knew I wanted to stay in the reprogram-
ming fi   eld. And at that point, there 
wasn’t any other lab where I could re-
ally learn more. Rudolf’s lab is one of 
the few that has all of these technolo-
gies together. Anything you can think of 
in mouse genetics or mouse embryology 
has happened in his lab, whether it’s 
making mice from embryonic stem 
cells, making transgenic mice, nuclear 
transfer, embryonic stem cell biology, 
studying cancer models, or embryonic 
development.
What was life like in the Jaenisch Lab?
It was very rewarding. I would say most 
of what I know now I learned in his lab.
It’s also a very critical lab. You learn 
very quickly in the lab meetings that you 
have to justify your interpretation of data. 
You learn how to think critically. I think 
that’s a very important part of the training 
that everyone goes through. Rudolf 
pushes you hard, and that’s good.
NEW DEVELOPMENT
You’ve recently set up your own lab at 
Harvard. Have you continued the 
tradition of tough-love lab meetings?
Probably, subconsciously. I think you do 
things in the way you’ve been trained by 
your mentor. I try to be as critical as 
Rudolf used to be with me, and I hope it 
pays off with my people.
How has it been setting up the new lab?
It was stressful in the beginning in terms 
of hiring people, getting your experi-
ments to work again, your cells to grow, 
your mice to breed, getting adjusted to a 
new environment, and to new colleagues. 
There are new responsibilities. All of a 
sudden you have to manage people. You 
have to make sure that their salaries are 
paid, that they’re happy, and that they are 
making progress in their experiments.
But the more I’m experiencing it, the 
more I like it. It’s really very rewarding to 
see people excited about the work they do.
Nuclear transfer can be a very ﬁ  ckle 
technique. Have you managed to set 
that up in your new lab?
It was a little diffi  cult at the beginning to 
optimize it and to make all the special 
culture media for growing the cloned 
embryos. But the system is working now.
But actually I’ve recently become 
interested in an alternative way of re-
programming: using defi  ned factors or 
genes. This is based on a landmark study 
by Shinya Yamanaka, published last 
year, that showed that just four defi  ned 
factors, when introduced into skin cells, 
are suffi  cient to turn these cells back into 
embryonic stem cells. We’ve recently 
reproduced this data and extended the 
original fi  ndings.
Four factors? That’s all you need to be 
embryonic again?
People were very skepti-
cal that this was true and 
wondered whether there 
might be an alternative 
interpretation to the re-
sults. But recently, three 
groups, Yamanaka again, 
Rudy Jaenisch, and our 
group, independently re-
produced the data. I 
think the fi  eld will now 
believe it. I certainly do.
Where do you plan to 
go with this?
It allows us now to study 
reprogramming at a mo-
lecular level, which was impossible to 
do with nuclear transfer or cell fusion, 
because you had such limited cellular 
material. You can take large numbers of 
cells, expose them to these four factors, 
and ask what happens at the molecular 
level, what genes are turned on.
We know very little about the process, 
about what exactly goes on at the level of 
DNA and chromatin. What is downstream 
of those four factors? That’s something 
I’m very interested in pursuing.
We also want to ask whether differ-
ent cell types can be reprogrammed by 
the same four factors. If it works in hu-
mans, there are therapeutic implica-
tions. It may circumvent the ethical and 
logistical limitations associated with 
nuclear transfer.
This fi   nding has revolutionized the 
entire stem cell and reprogramming fi  eld 
and has opened up many new avenues of 
research. I think we’ll see a lot more 
exciting research in that area in the next 
few years, or even months.
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to see people 
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Reprogrammed ﬁ  broblasts (green) can develop into different 
tissue types in a newborn chimeric mouse.